Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

205 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Living with Chronic Spontaneous Urticaria in Italy: A Narrative Medicine Project to Improve the Pathway of Patient Care.
Cappuccio A, Limonta T, Parodi A, Cristaudo A, Bugliaro F, Cannavò SP, Rossi O, Gurioli C, Vignoli A, Parente R, Iemoli E, Caldarola G, De Pità O, Di Nuzzo S, Cancian M, Potenza C, Caminati M, Stingeni L, Saraceno R, Trevisini S, Piccirillo A, Sciarrone C, Panebianco R, Gola M, Costanzo A, Grieco T, Massaroni K, Reale L, Marini MG. Cappuccio A, et al. Among authors: cannavo sp. Acta Derm Venereol. 2017 Jan 4;97(1):81-85. doi: 10.2340/00015555-2478. Acta Derm Venereol. 2017. PMID: 27275626 Free article.
Clinical epidemiology of hand eczema in patients accessing dermatological reference centres: results from Italy.
Scalone L, Cortesi PA, Mantovani LG, Belisari A, Ayala F, Fortina AB, Bonamonte D, Borroni G, Cannavò SP, Guarneri F, Cristaudo A, De Pità O, Gallo R, Girolomoni G, Gola M, Lisi P, Pigatto PD, Satta R, Giannetti A; Italian Hand Eczema Study Group. Scalone L, et al. Among authors: cannavo sp. Br J Dermatol. 2015 Jan;172(1):187-95. doi: 10.1111/bjd.13220. Epub 2014 Nov 21. Br J Dermatol. 2015. PMID: 24974982
Management of biological therapies for chronic plaque psoriasis during COVID-19 emergency in Italy.
Talamonti M, Galluzzo M, Chiricozzi A, Quaglino P, Fabbrocini G, Gisondi P, Marzano AV, Potenza C, Conti A, Parodi A, Belloni Fortina A, Bardazzi F, Argenziano G, Rongioletti F, Stingeni L, Micali G, Loconsole F, Venturini M, Bongiorno MR, Feliciani C, Rubegni P, Amerio P, Fargnoli MC, Pigatto P, Savoia P, Nisticò SP, Giustini S, Carugno A, Cannavò SP, Rech G, Prignano F, Offidani A, Lombardo M, Zalaudek I, Bianchi L, Peris K; PSO-BIO-COVID study group. Talamonti M, et al. Among authors: cannavo sp. J Eur Acad Dermatol Venereol. 2020 Dec;34(12):e770-e772. doi: 10.1111/jdv.16841. Epub 2020 Aug 10. J Eur Acad Dermatol Venereol. 2020. PMID: 32735716 Free PMC article. No abstract available.
Characteristic of chronic plaque psoriasis patients treated with biologics in Italy during the COVID-19 Pandemic: Risk analysis from the PSO-BIO-COVID observational study.
Talamonti M, Galluzzo M, Chiricozzi A, Quaglino P, Fabbrocini G, Gisondi P, Marzano AV, Potenza C, Conti A, Parodi A, Piaserico S, Bardazzi F, Argenziano G, Rongioletti F, Stingeni L, Micali G, Loconsole F, Rossi MT, Bongiorno MR, Feliciani C, Rubegni P, Amerio P, Fargnoli MC, Pigatto P, Savoia P, Nisticò SP, Giustini S, Carugno A, Cannavo' SP, Rech G, Prignano F, Offidani A, Lombardo M, Zalaudek I, Bianchi L, Peris K; PSO-BIO-COVID study group; Balestri R, Bernardini N, Belloni Fortini A, Burlando M, Caldarola G, Campione E, Cattaneo A, Dapavo P, Dastoli S, De Simone C, Di Nuzzo S, Diotallevi F, Fierro MT, Franchi C, Esposito M, Foti C, Gambini DM, Gambardella A, Girolomoni G, Giunta A, Guarneri C, Gualdi G, Hansel K, Megna M, Mugheddu C, Musumeci ML, Patrizi A, Pellacani G, Richetta AG, Rosi E, Sacchelli L, Tiberio R, Tilotta G, Trovato E, Venturini M, Vezzoni R. Talamonti M, et al. Among authors: cannavo sp. Expert Opin Biol Ther. 2021 Feb;21(2):271-277. doi: 10.1080/14712598.2021.1853698. Epub 2021 Jan 13. Expert Opin Biol Ther. 2021. PMID: 33216643
DECISA Project (DErmatology Clinics in Italy: Survey on Alitretinoin): A real-life retrospective cohort multicenter study on 438 subjects with chronic hand eczema.
Ferrucci S, Persichini P, Gola M, Scandagli I, Pigatto P, Legori A, Musumeci ML, Micali G, D'Agata E, Schena D, Azzolini A, Gallo R, Trave I, Cristaudo A, Patruno C, Napolitano M, Zucca M, Piras V, Stingeni L, Bianchi L, Corazza M, Zedde P, Foti C, Romita P, Cannavò SP, Guarneri F. Ferrucci S, et al. Among authors: cannavo sp. Dermatol Ther. 2021 May;34(3):e14911. doi: 10.1111/dth.14911. Epub 2021 Mar 9. Dermatol Ther. 2021. PMID: 33619833
Analysis of clinical factors as possible predictors of response to omalizumab and relapse after treatment discontinuation in chronic spontaneous urticaria.
Foti C, Romita P, Ambrogio F, Fanelli M, Panebianco R, Vena GA, Cassano N, Ragusa M, Giuffrida R, Papaianni V, Borgia F, Cannavò SP, Guarneri F. Foti C, et al. Among authors: cannavo sp. Dermatol Ther. 2022 Feb;35(2):e15248. doi: 10.1111/dth.15248. Epub 2021 Dec 16. Dermatol Ther. 2022. PMID: 34877757
Real-life experience on effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitis.
Fargnoli MC, Esposito M, Ferrucci S, Girolomoni G, Offidani A, Patrizi A, Peris K, Costanzo A, Malara G, Pellacani G, Romanelli M, Amerio P, Cristaudo A, Flori ML, Motolese A, Betto P, Patruno C, Pigatto P, Sirna R, Stinco G, Zalaudek I, Bianchi L, Boccaletti V, Cannavò SP, Cusano F, Lembo S, Mozzillo R, Gallo R, Potenza C, Rongioletti F, Tiberio R, Grieco T, Micali G, Persechino S, Pettinato M, Pucci S, Savi E, Stingeni L, Romano A, Argenziano G; Dupilumab Italian National Access Program (Dup-INAP group). Fargnoli MC, et al. Among authors: cannavo sp. J Dermatolog Treat. 2021 Aug;32(5):507-513. doi: 10.1080/09546634.2019.1682503. Epub 2019 Oct 28. J Dermatolog Treat. 2021. PMID: 31647347 Free article.
205 results